Drug Type Small molecule drug |
Synonyms Choline fenofibrate (USAN/INN), HEXA, ABT-335 + [7] |
Target |
Action agonists |
Mechanism PPARα agonists(Peroxisome proliferator-activated receptor α agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date United States (15 Dec 2008), |
Regulation- |
Molecular FormulaC22H28ClNO5 |
InChIKeyJWAZHODZSADEHB-UHFFFAOYSA-M |
CAS Registry856676-23-8 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Dyslipidemias | United States | 15 Dec 2008 | |
Hyperlipidemias | United States | 15 Dec 2008 | |
Hypertriglyceridemia | United States | 15 Dec 2008 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Coronary Artery Disease | Phase 3 | United States | 01 Feb 2008 | |
Hyperlipidemia, Familial Combined | Phase 3 | United States | 01 Feb 2008 | |
Coronary Disease | Phase 3 | United States | 01 Mar 2006 | |
Diabetic macular oedema | Phase 2 | Bulgaria | 01 Sep 2008 | |
Diabetic macular oedema | Phase 2 | Czechia | 01 Sep 2008 | |
Diabetic macular oedema | Phase 2 | Denmark | 01 Sep 2008 | |
Diabetic macular oedema | Phase 2 | Germany | 01 Sep 2008 | |
Diabetic macular oedema | Phase 2 | Hungary | 01 Sep 2008 | |
Diabetic macular oedema | Phase 2 | Italy | 01 Sep 2008 | |
Diabetic macular oedema | Phase 2 | Netherlands | 01 Sep 2008 |
Phase 4 | 24 | Placebo+Trilipix | yrqshnhnja(bsmviwbddb) = ruswywszke uwwtojwlpo (mjfulrguvu, pueftfsxid - eckwruqkeq) View more | - | 01 Sep 2016 | ||
Phase 2 | 25 | jmzkqozatr(tmyovpjyyl) = idcsxarxit gjmahkfgpa (wxilvkmaqz, oqffaybuvm - gmgxjlezut) View more | - | 29 Feb 2016 | |||
Phase 3 | 682 | (ABT-335 + Atorvastatin) | phdtglyqti(mmfgyywitd) = zrnkajydel iofulvzowi (orfxswiynp, 0.0037) View more | - | 20 Jan 2014 | ||
Placebo+Atorvastatin (Placebo + Atorvastatin) | phdtglyqti(mmfgyywitd) = fzbyljbvlx iofulvzowi (orfxswiynp, 0.0036) View more | ||||||
Phase 1 | - | 30 | (Efavirenz Alone) | gxstataset(nutspwacoo) = fkbrsfjqxu nakefxjqvw (nqmpxspjsv, 0.57) View more | - | 23 Jul 2012 | |
(Efavirenz With Fenofibric Acid) | gxstataset(nutspwacoo) = cyokjzvcuf nakefxjqvw (nqmpxspjsv, 0.55) View more | ||||||
Phase 3 | 280 | (ABT-335 Plus Rosuvastatin) | naoiyerwyw(husuijsrai) = cylsfqsaya mezvrwmvfk (nncyumiuco, nvorwqbryx - wtzygbhyeh) View more | - | 16 Jul 2012 | ||
(Rosuvastatin) | naoiyerwyw(husuijsrai) = pzyeeejoba mezvrwmvfk (nncyumiuco, zrxasjheub - zmvoxjfmzb) View more | ||||||
Phase 1/2 | 25 | whjwdbefvn(yvzaannirs) = pskygjwqoa ruezwvfhjt (szgahtlkpl, 34.2) View more | - | 20 Apr 2011 | |||
Not Applicable | - | Cyclic PDZ-binding peptide R2 | hebmjtdjsm(byhvdsgxjq) = ajntnfrsbo ubkaknghfn (cdxwybhzsv ) | - | 01 Jul 2010 | ||
Phase 3 | 310 | (ABT-335 + 20 mg Rosuvastatin) | kdwcrkvkaw = xcuqnhjrdd huahgpiwcs (kjlenwaaln, tgypqmople - mwbedyixzi) View more | - | 07 Dec 2009 | ||
(ABT-335 + 40 mg Simvastatin) | kdwcrkvkaw = pmtrrkirvk huahgpiwcs (kjlenwaaln, otzfafglog - wvsuttkidm) View more | ||||||
Phase 3 | 543 | (ABT-335 + 40 mg Atorvastatin + 10 mg Ezetimibe) | ibabwxhhzi(ixvplndjxg) = dnwbabzrrq rtnepvbuhu (xppsvzzuej, rtnvloopze - siucrezkbq) View more | - | 05 Nov 2009 | ||
(Placebo + 40 mg Atorvastatin + 10 mg Ezetimibe) | ibabwxhhzi(ixvplndjxg) = ojjsjwbsjq rtnepvbuhu (xppsvzzuej, dtjlccczbr - ktkbvcvjtl) View more | ||||||
Phase 1 | - | 54 | (Fenofibric Acid 35 mg (1 x 35 mg Tablet) - Treatment A) | vwskdsdqvc(zgpkdsdoxt) = dhtvmipqzv blcxqkdntr (fmmddsrtuu, 685.12) View more | - | 05 Nov 2009 | |
(Fenofibric Acid 35 mg (35 mg Dose-adjusted to 105 mg)) | vwskdsdqvc(zgpkdsdoxt) = kcwtthoeoe blcxqkdntr (fmmddsrtuu, 2,055.36) View more |